Table 5. Influence of age on survival and cause of death in rectal cancer.
| Age | <61.27 | 61.27-67.98 | 67.98-78.06 | 78.06- | Total |
|---|---|---|---|---|---|
| Total | 36 | 35 | 36 | 36 | 143 |
| Gender | |||||
| Male | 23 (63.90%) | 22 (62.90%) | 23 (63.90%) | 16 (44.40%) | 84 (58.70%) |
| Female | 13 (36.10%) | 13 (37.10%) | 13 (36.10%) | 20 (55.60%) | 59 (41.30%) |
| Median survival (IQR) | 3.79 (1.96-6.61) | 5.09 (1.75-7.51) | 4.54 (1.63-7.99) | 5.55 (1.04-7.90) | 4.67 (1.67-7.34) |
| 1-year survival | 32 (88.90%) | 30 (85.70%) | 30 (83.30%) | 28 (77.80%) | 120 (83.90%) |
| 5-year survival | 17 (47.20%) | 18 (51.40%) | 16 (44.40%) | 19 (52.80%) | 70 (49.00%) |
| Cause of death | |||||
| Tumor progression | 16 (44.40%) | 14 (40.00%) | 14 (38.90%) | 7 (19.40%) | 51 (35.70%) |
| Tx | 2 (5.60%) | 4 (11.40%) | 3 (8.30%) | 3 (8.30%) | 12 (8.40%) |
| Other | 1 (2.80%) | 2 (5.70%) | 3 (8.30%) | 14 (38.90%) | 20 (14.00%) |
| Unknown | 4 (11.10%) | 2 (5.70%) | 4 (11.10%) | 1 (2.80%) | 11 (7.70%) |
| Alive | 13 (36.10%) | 13 (37.10%) | 12 (33.20%) | 11 (30.60%) | 49 (34.30%) |
| Other + Tx/(other + Tx + tumor progression) | 3/19 (15.80%) | 6/18 (33.30%) | 6/20 (30.00%) | 17/24 (70.80%) | 32/83 (38.60%) |
| Mean Charlson score | 0.64 | 0.63 | 1.00 | 0.89 | 0.79 |
| TNM stage | |||||
| 0-1 | 4 (11.80%) | 4 (11.80%) | 4 (11.40%) | 7 (23.30%) | 19 (14.30%) |
| 2 | 12 (35.30%) | 13 (38.20%) | 9 (25.70%) | 11 (36.70%) | 45 (33.80%) |
| 3 | 6 (17.60%) | 7 (20.60%) | 16 (45.70%) | 9 (30.00%) | 38 (28.60%) |
| 4 | 12 (35.30%) | 10 (29.40%) | 6 (17.10%) | 3 (10.00%) | 31 (23.30%) |
IQR, interquartile range.